Hepion Pharmaceuticals Files 2025 Annual Report
Ticker: HEPA · Form: ARS · Filed: Apr 28, 2026 · CIK: 0001583771
| Field | Detail |
|---|---|
| Company | Hepion Pharmaceuticals, Inc. (HEPA) |
| Form Type | ARS |
| Filed Date | Apr 28, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, pharmaceuticals, sec-filing
TL;DR
Hepion Pharma dropped its 2025 ARS on 4/28. Check it for deets.
AI Summary
Hepion Pharmaceuticals, Inc. filed its Annual Report to Security Holders (ARS) on April 28, 2026, for the period ending December 31, 2025. The company, headquartered in Red Bank, NJ, is involved in the pharmaceutical preparations industry. This filing provides a summary of the company's performance and financial standing for the fiscal year 2025.
Why It Matters
This filing provides shareholders and potential investors with a comprehensive overview of Hepion Pharmaceuticals' operations and financial health for the past fiscal year, aiding in investment decisions.
Risk Assessment
Risk Level: low — This is a routine annual report filing and does not contain new material information that would inherently increase risk.
Key Numbers
- 2025 — Fiscal Year End (Period covered by the ARS filing)
- 739081 — ARS Document Size (Size of the ARS PDF document)
Key Players & Entities
- Hepion Pharmaceuticals, Inc. (company) — Filer of the ARS
- 34 SHREWSBURY AVE. SUITE 1D RED BANK NJ 07701 (location) — Mailing and Business Address
- 2025-12-31 (date) — Period of Report
- 2026-04-28 (date) — Filing Date
FAQ
What is the primary purpose of an ARS filing?
An ARS (Annual Report to Security Holders) filing provides shareholders with a comprehensive overview of the company's performance, financial condition, and activities for the past fiscal year.
When was this specific ARS filing accepted by the SEC?
This ARS filing was accepted by the SEC on April 28, 2026.
What is the period of report for this ARS filing?
The period of report for this ARS filing is December 31, 2025.
Where is Hepion Pharmaceuticals, Inc. located?
Hepion Pharmaceuticals, Inc. has its mailing and business address at 34 Shrewsbury Ave., Suite 1D, Red Bank, NJ 07701.
What industry does Hepion Pharmaceuticals, Inc. operate in?
Hepion Pharmaceuticals, Inc. operates in the Pharmaceutical Preparations industry, specifically classified under SIC code 2834.
Filing Details
This Form ARS (Form ARS) was filed with the SEC on April 28, 2026 regarding Hepion Pharmaceuticals, Inc. (HEPA).